{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T06:26:33Z","timestamp":1783578393677,"version":"3.55.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.ejphar.2025.178171","type":"journal-article","created":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T20:53:09Z","timestamp":1758055989000},"page":"178171","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["KN060-a humanized dual-domain antibody simultaneously targeting FXI-A2\/A3 epitopes: Pioneering the anti-coagulation factor XI strategy for Aterial hypertension \u2013 Evidence from preclinical models"],"prefix":"10.1016","volume":"1006","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8542-9310","authenticated-orcid":false,"given":"Xiaoyan","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doudou","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kangping","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenqiao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongmei","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihong","family":"Yun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0948-8191","authenticated-orcid":false,"given":"Jun","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2025.178171_bib1","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1093\/cvr\/cvad091","article-title":"Thrombin-activated interleukin-1 alpha drives atherogenesis, but also promotes vascular smooth muscle cell proliferation and collagen production","volume":"119","author":"Burzynski","year":"2023","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ejphar.2025.178171_bib2","doi-asserted-by":"crossref","first-page":"e07","DOI":"10.15420\/ecr.2023.51","article-title":"The global burden of resistant hypertension and potential treatment options","volume":"19","author":"Buso","year":"2024","journal-title":"Eur. Cardiol."},{"key":"10.1016\/j.ejphar.2025.178171_bib3","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S0140-6736(21)01330-1","article-title":"Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants","volume":"398","author":"Collaboration","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2025.178171_bib4","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1038\/sj.bjp.0707454","article-title":"Angiotensin AT1 receptor antagonists exert anti-inflammatory effects in spontaneously hypertensive rats","volume":"152","author":"Dai","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.178171_bib5","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2023.1221438","article-title":"Endothelial dysfunction, platelet hyperactivity, hypertension, and the metabolic syndrome: molecular insights and combating strategies","volume":"10","author":"Das","year":"2023","journal-title":"Front. Nutr."},{"issue":"Suppl. 1","key":"10.1016\/j.ejphar.2025.178171_bib6","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.1016\/j.thromres.2014.03.020","article-title":"The mechanism underlying activation of factor IX by factor XIa","volume":"133","author":"Gailani","year":"2014","journal-title":"Thromb. Res."},{"key":"10.1016\/j.ejphar.2025.178171_bib7","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1358\/dof.2021.46.12.3349024","article-title":"Abelacimab, anti-factor XI\/XIa monoclonal antibody, treatment of atrial fibrillation, treatment of thrombotic disorders","volume":"46","author":"Hardy","year":"2021","journal-title":"Drugs Future"},{"key":"10.1016\/j.ejphar.2025.178171_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22168664","article-title":"Thrombin inhibition prevents endothelial dysfunction and reverses 20-HETE overproduction without affecting blood pressure in angiotensin II-Induced hypertension in mice","volume":"22","author":"Kij","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2025.178171_bib9","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1182\/blood-2018-10-880849","article-title":"MAA868, a novel FXI antibody with a unique binding mode, shows durable effects on markers of anticoagulation in humans","volume":"133","author":"Koch","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.ejphar.2025.178171_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2023.102276","article-title":"Activation of coagulation FXI promotes endothelial inflammation and amplifies platelet activation in a nonhuman primate model of hyperlipidemia","volume":"8","author":"Kohs","year":"2024","journal-title":"Res. Pract. Thromb. Haemost."},{"key":"10.1016\/j.ejphar.2025.178171_bib11","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aah4923","article-title":"Platelet-localized FXI promotes a vascular coagulation-inflammatory circuit in arterial hypertension","volume":"9","author":"Kossmann","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ejphar.2025.178171_bib12","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/hr.2016.145","article-title":"Vascular structural and functional changes: their association with causality in hypertension: models, remodeling and relevance","volume":"40","author":"Lee","year":"2017","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.ejphar.2025.178171_bib13","article-title":"Effects of long-term intervention with losartan, aspirin and atorvastatin on vascular remodeling in juvenile spontaneously hypertensive rats","volume":"28","author":"Liu","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.ejphar.2025.178171_bib14","doi-asserted-by":"crossref","first-page":"C377","DOI":"10.1152\/ajpcell.00426.2018","article-title":"Coagulation factor XI induces Ca(2+) response and accelerates cell migration in vascular smooth muscle cells via proteinase-activated receptor 1","volume":"316","author":"Liu","year":"2019","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.ejphar.2025.178171_bib15","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1161\/ATVBAHA.118.312328","article-title":"Contact activation inhibitor and factor XI antibody, AB023, produces safe, dose-dependent anticoagulation in a phase 1 first-in-human trial","volume":"39","author":"Lorentz","year":"2019","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ejphar.2025.178171_bib16","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.thromres.2017.10.008","article-title":"An update on factor XI structure and function","volume":"161","author":"Mohammed","year":"2018","journal-title":"Thromb. Res."},{"key":"10.1016\/j.ejphar.2025.178171_bib17","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.e7473","article-title":"Resistant hypertension","volume":"345","author":"Myat","year":"2012","journal-title":"Br. Med. J."},{"key":"10.1016\/j.ejphar.2025.178171_bib18","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1038\/s41440-021-00700-7","article-title":"Rivaroxaban attenuates cardiac hypertrophy by inhibiting protease-activated receptor-2 signaling in renin-overexpressing hypertensive mice","volume":"44","author":"Narita","year":"2021","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.ejphar.2025.178171_bib19","doi-asserted-by":"crossref","first-page":"9761","DOI":"10.1038\/s41598-022-13174-5","article-title":"Association of FXI activity with thrombo-inflammation, extracellular matrix, lipid metabolism and apoptosis in venous thrombosis","volume":"12","author":"Pallares Robles","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2025.178171_bib20","first-page":"8","article-title":"A new therapeutic principle in anticoagulation","volume":"27","author":"Pratintip Lee","year":"2024","journal-title":"Cardiovasc. Med."},{"key":"10.1016\/j.ejphar.2025.178171_bib21","series-title":"Regeneron Corporate Presentation","year":"2025"},{"key":"10.1016\/j.ejphar.2025.178171_bib22","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1056\/NEJMoa2406674","article-title":"Abelacimab versus rivaroxaban in patients with atrial fibrillation","volume":"392","author":"Ruff","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2025.178171_bib23","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2023-079108","article-title":"Diagnosis and management of resistant hypertension","volume":"385","author":"Schiffrin","year":"2024","journal-title":"Br. Med. J."},{"key":"10.1016\/j.ejphar.2025.178171_bib24","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1055\/s-0041-1735971","article-title":"The association between factor XI deficiency and the risk of bleeding, cardiovascular, and venous thromboembolic events","volume":"122","author":"Sharman Moser","year":"2022","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.ejphar.2025.178171_bib25","doi-asserted-by":"crossref","first-page":"4762","DOI":"10.1182\/blood-2011-10-386185","article-title":"Inhibition of factor XI activation attenuates inflammation and coagulopathy while improving the survival of mouse polymicrobial sepsis","volume":"119","author":"Tucker","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.ejphar.2025.178171_bib26","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1056\/NEJMoa2105872","article-title":"Abelacimab for prevention of venous thromboembolism","volume":"385","author":"Verhamme","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2025.178171_bib27","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1182\/bloodadvances.2022008720","article-title":"A novel mouse whole blood thrombin generation assay sensitive to FXI- and FIX-mediated amplification of coagulation","volume":"7","author":"Wan","year":"2023","journal-title":"Blood Adv."},{"key":"10.1016\/j.ejphar.2025.178171_bib28","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3389\/fmed.2017.00019","article-title":"Factors XI and XII as targets for new anticoagulants","volume":"4","author":"Weitz","year":"2017","journal-title":"Front. Med."},{"key":"10.1016\/j.ejphar.2025.178171_bib29","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1590\/S0100-879X2007000500018","article-title":"Sex differences in angiotensin II- induced hypertension","volume":"40","author":"Xue","year":"2007","journal-title":"Braz. J. Med. Biol. Res."},{"key":"10.1016\/j.ejphar.2025.178171_bib30","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1253\/jcj.41.259","article-title":"Pathogenesis of spontaneous hypertension as a model for essential hypertension","volume":"41","author":"Yamori","year":"1977","journal-title":"Jpn. Circ. J."},{"key":"10.1016\/j.ejphar.2025.178171_bib31","doi-asserted-by":"crossref","DOI":"10.1038\/celldisc.2017.4","article-title":"Structural basis of a novel PD-L1 nanobody for immune checkpoint blockade","volume":"3","author":"Zhang","year":"2017","journal-title":"Cell Discov."},{"key":"10.1016\/j.ejphar.2025.178171_bib32","article-title":"Role of inflammation, immunity, and oxidative stress in hypertension: new insights and potential therapeutic targets","volume":"13","author":"Zhang","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejphar.2025.178171_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijgc.2025.101706","article-title":"SHR-2004, A novel humanised monoclonal antibody targeting factor XI (FXI), for preventing venous thromboembolism (VTE) in patients undergoing surgery for ovarian cancer: a randomised, active-control phase 2 study, 2025 ESGO","author":"Zhu","year":"2025","journal-title":"Int. J. Gynecol. Cancer"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299925009252?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299925009252?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,31]],"date-time":"2026-05-31T04:34:25Z","timestamp":1780202065000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299925009252"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":33,"alternative-id":["S0014299925009252"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.178171","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"KN060-a humanized dual-domain antibody simultaneously targeting FXI-A2\/A3 epitopes: Pioneering the anti-coagulation factor XI strategy for Aterial hypertension \u2013 Evidence from preclinical models","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.178171","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"178171"}}